Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.

about

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.

Item

http://www.wikidata.org/entity/Q47293306

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adjunctive perampanel in parti ...... c, randomized phase III study.

@en

Adjunctive perampanel in parti ...... c, randomized phase III study.

@nl

type

Item

label

Adjunctive perampanel in parti ...... c, randomized phase III study.

@en

Adjunctive perampanel in parti ...... c, randomized phase III study.

@nl

prefLabel

Adjunctive perampanel in parti ...... c, randomized phase III study.

@en

Adjunctive perampanel in parti ...... c, randomized phase III study.

@nl

P1476

Adjunctive perampanel in parti ...... c, randomized phase III study.

@en

P2093

K Ishikawa

http://www.w3.org/2001/XMLSchema#string

K Saeki

http://www.w3.org/2001/XMLSchema#string

S K Lee

http://www.w3.org/2001/XMLSchema#string

S Kaneko

http://www.w3.org/2001/XMLSchema#string

T Nishida

http://www.w3.org/2001/XMLSchema#string

Y Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

Neuroimaging predictors of AED resistance in new-onset epilepsies.

Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy.

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.

Combined analysis of risk factors for SUDEP.

Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy.

Interictal-like network activity and receptor expression in the epileptic human lateral amygdala.

P31

scholarly article

P356

10.1111/ANE.12883

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250772

http://www.w3.org/2001/XMLSchema#string